192 related articles for article (PubMed ID: 37344166)
1. Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
Charlesworth JEG; Kavirayani A
Eur J Haematol; 2023 Sep; 111(3):458-476. PubMed ID: 37344166
[TBL] [Abstract][Full Text] [Related]
2. Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children.
Charlesworth JEG; Wilson S; Qureshi A; Blanco E; Mitchell A; Segal S; Kelly D; Weitz J; O'Shea D; Bailey K; Kavirayani A
Pediatr Blood Cancer; 2021 Sep; 68(9):e29102. PubMed ID: 34114322
[TBL] [Abstract][Full Text] [Related]
3. The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Bami S; Vagrecha A; Soberman D; Badawi M; Cannone D; Lipton JM; Cron RQ; Levy CF
Pediatr Blood Cancer; 2020 Nov; 67(11):e28581. PubMed ID: 32725881
[TBL] [Abstract][Full Text] [Related]
4. A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Kumar B; Aleem S; Saleh H; Petts J; Ballas ZK
J Clin Immunol; 2017 Oct; 37(7):638-643. PubMed ID: 28871523
[TBL] [Abstract][Full Text] [Related]
5. Intravenous administration of anakinra in children with macrophage activation syndrome.
Phadke O; Rouster-Stevens K; Giannopoulos H; Chandrakasan S; Prahalad S
Pediatr Rheumatol Online J; 2021 Jun; 19(1):98. PubMed ID: 34187503
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP).
Sandler RD; Tattersall RS; Schoemans H; Greco R; Badoglio M; Labopin M; Alexander T; Kirgizov K; Rovira M; Saif M; Saccardi R; Delgado J; Peric Z; Koenecke C; Penack O; Basak G; Snowden JA
Front Immunol; 2020; 11():524. PubMed ID: 32296434
[No Abstract] [Full Text] [Related]
7. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
8. Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.
Eloseily EM; Weiser P; Crayne CB; Haines H; Mannion ML; Stoll ML; Beukelman T; Atkinson TP; Cron RQ
Arthritis Rheumatol; 2020 Feb; 72(2):326-334. PubMed ID: 31513353
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
Karakike E; Giamarellos-Bourboulis EJ
Front Immunol; 2019; 10():55. PubMed ID: 30766533
[TBL] [Abstract][Full Text] [Related]
10. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
12. Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma.
Pascarella A; Bracaglia C; Caiello I; Arduini A; Moneta GM; Rossi MN; Matteo V; Pardeo M; De Benedetti F; Prencipe G
Front Immunol; 2021; 12():663329. PubMed ID: 33815425
[TBL] [Abstract][Full Text] [Related]
13. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome.
Mehta P; Cron RQ; Hartwell J; Manson JJ; Tattersall RS
Lancet Rheumatol; 2020 Jun; 2(6):e358-e367. PubMed ID: 32373790
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019.
Wampler Muskardin TL
ACR Open Rheumatol; 2020 May; 2(5):283-285. PubMed ID: 32267072
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
16. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
17. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
Krei JM; Møller HJ; Larsen JB
Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
[TBL] [Abstract][Full Text] [Related]
18. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW;
Ann Rheum Dis; 2023 Oct; 82(10):1271-1285. PubMed ID: 37487610
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment.
Carter SJ; Tattersall RS; Ramanan AV
Rheumatology (Oxford); 2019 Jan; 58(1):5-17. PubMed ID: 29481673
[TBL] [Abstract][Full Text] [Related]
20. Does your unwell patient have haemophagocytic lymphohistiocytosis?
Holloway A; Ahmed S; Manson JJ
Br J Hosp Med (Lond); 2024 Mar; 85(3):1-12. PubMed ID: 38557089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
